BIG PHARMA EARNINGS WATCH: SANOFI
Feb 2, 2026
Sanofi Beats Wall Street Expectations, Touts Anti-Competitive Strategy on… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jan 26, 2026
Johnson & Johnson Beats Wall Street Expectations; Raises Sales Forecasts… Read More
DOSE OF REALITY: NEW CMS DATA UNDERSCORES HOW BIG PHARMA’S EGREGIOUS PRICING PRACTICES ARE DRIVING INCREASED HEALTH CARE COSTS
Jan 26, 2026
U.S. Prescription Drug Spending Climbs as Big Pharma Sets New Records for… Read More
DOSE OF REALITY: BIG PHARMA’S EGREGIOUS PRICING AND ANTI-COMPETITIVE PRACTICES ARE DRIVING RISING HEALTH CARE COSTS
Jan 22, 2026
Making Health Care Affordable for the American People Means Holding Big Pharma… Read More
DOSE OF REALITY: DRUG MAKERS INCREASINGLY UTILIZING DEVICE PATENTS TO EXTEND EXCLUSIVITY ON BLOCKBUSTER DRUGS
Jan 9, 2026
New Research Shows Drugmakers Increasingly Rely on Patents Disconnected from… Read More
DOSE OF REALITY: NEW REPORT PROJECTS MORE THAN 50 PERCENT DROP IN OUT-OF-POCKET COSTS FOR TOP MEDICARE DRUGS IN 2026
Jan 6, 2026
AARP Analysis Highlights Substantial Cost Savings for Nearly Nine Million… Read More
Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part IV: Big Pharma’s Debunked Innovation Rhetoric
Dec 31, 2025
Big Pharma Undercut Its Own False Claims About Innovation in 2025 With each… Read More
Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part III: Big Pharma’s Anti-Competitive Tactics That Keep Prices High
Dec 30, 2025
Exploring Big Pharma’s Egregious Abuse of the Patent System Designed to… Read More
Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part II: Big Pharma’s DTC Advertising
Dec 29, 2025
Big Pharma’s Aggressive Marketing Directly Targeting Consumers to Boost… Read More
Dose of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part I: Big Pharma’s Egregious Pricing Practices
Dec 29, 2025
Take a Look Back on Big Pharma’s Year of Price Hikes and Increasingly… Read More
THEY SAID IT! U.S. REPRESENTATIVE DAVE TAYLOR CALLS FOR LIST PRICE TRANSPARENCY IN BIG PHARMA’S DIRECT-TO-CONSUMER ADVERTISING
Dec 17, 2025
Lawmaker Highlights Broad-Based Support for Bipartisan Solution to Disclose… Read More
THEY SAID IT! BIPARTISAN GROUP OF LAWMAKERS URGE ADMINISTRATION TO SUPPORT CRACKDOWN ON BIG PHARMA’S PATENT THICKETS
Dec 16, 2025
Members of Congress Say Addressing “Patent Thickets Surrounding Branded… Read More